Article
Identification of bazedoxifene for the treatment of LGMD R2 by high throughput screening
2024-03-04
Abstract excerpt
LGMD R2 is a rare genetic disorder characterized by progressive proximal muscle weakness and wasting caused by a recessive loss of function of dysferlin, a transmembrane protein controlling plasma membrane repair in skeletal muscles. We report here the development of an in vitro high-throughput assay using immortalized myoblasts and monitored reallocation of an aggregated mutant form of dysferlin ( DYSF L1341P )...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ba39649a-e391-588f-9a47-475358ebaabc
- DOI
- 10.1101/2024.02.28.582550
